Saltar al contenido
MilliporeSigma

Systemic delivery of factor IX messenger RNA for protein replacement therapy.

Proceedings of the National Academy of Sciences of the United States of America (2017-02-17)
Suvasini Ramaswamy, Nina Tonnu, Kiyoshi Tachikawa, Pattraranee Limphong, Jerel B Vega, Priya P Karmali, Pad Chivukula, Inder M Verma
RESUMEN

Safe and efficient delivery of messenger RNAs for protein replacement therapies offers great promise but remains challenging. In this report, we demonstrate systemic, in vivo, nonviral mRNA delivery through lipid nanoparticles (LNPs) to treat a Factor IX (

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
1,2-Dimyristoyl-sn-glycerol, ≥95%